2022 ESC术前心脏检查指南相关病理发现:观察性队列建模研究
该研究基于MET-REPAIR国际前瞻性观察队列(n=15,529),量化2022 ESC术前评估更新对病理发现检出率的影响。更新使39.7%患者TTE推荐等级改变、12.9%患者负荷影像推荐改变;TTE新推荐未提高病理检出率,NT-proBNP未改善检出,指南依从性与MACE无关联。
要点
- 2022 ESC更新使39.7%患者TTE推荐等级改变,12.9%患者负荷影像推荐改变。
- TTE新推荐每减少3例检查即漏诊1例EF<40%,负荷影像每多检出1例缺血需多做4例检查。
- NT-proBNP未改善病理发现检出率,指南依从性与MACE无关联。
核心结论
- 2022 ESC术前心脏检查更新使更多检查获得更强推荐,但TTE新推荐未提高病理心脏检查的检出率。
研究设计与样本
- MET-REPAIR国际前瞻性观察队列(NCT03016936)的二次分析,纳入15,529例患者(39%女性,中位年龄72岁[IQR 67-78])。
- 采用二阶蒙特卡洛模拟和多变量回归,主要终点为EF<40%、负荷诱发缺血和MACE。
主要发现
- 2022更新使39.7%患者术前TTE推荐等级改变,12.9%患者术前负荷影像推荐等级改变。
- 更新导致每少做3例TTE即漏诊1例EF<40%,每多检出1例缺血事件需额外做4例负荷影像。
- 使用NT-proBNP未改善病理发现检出率;多变量回归未发现指南依从性与MACE的关联。
关键数值与推荐
- 2022 ESC指南更新了术前心脏检查推荐等级,具体推荐条款未在摘要中列出。
临床怎么用
- 麻醉科医生应知晓2022 ESC更新使更多患者接受更强推荐的术前心脏检查,但TTE新推荐未提高病理检出率。
- 术前NT-proBNP用于风险估计未改善病理发现检出,指南依从性与MACE无关联,临床决策需综合评估。
局限性
- 本研究为观察性队列的二次分析,结果可能受混杂影响。
- 摘要未报告具体推荐条款、效应量置信区间及P值等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2022, the European Society of Cardiology updated guidelines for preoperative evaluation. The aims of this study were to quantify: (1) the impact of the updated recommendations on the yield of pathological findings compared with the previous guidelines published in 2014; (2) the impact of preoperative B-type natriuretic peptide (NT-proBNP) use for risk estimation on the yield of pathological findings; and (3) the association between 2022 guideline adherence and outcomes. METHODS: This was a secondary analysis of MET-REPAIR, an international, prospective observational cohort study (NCT03016936). Primary endpoints were reduced ejection fraction (EF<40%), stress-induced ischaemia, and major adverse cardiovascular events (MACE). The explanatory variables were class of recommendations for transthoracic echocardiography (TTE), stress imaging, and guideline adherence. We conducted second-order Monte Carlo simulations and multivariable regression. RESULTS: In total, 15,529 patients (39% female, median age 72 [inter-quartile range: 67-78] yr) were included. The 2022 update changed the recommendation for preoperative TTE in 39.7% patients, and for preoperative stress imaging in 12.9% patients. The update resulted in missing 1 EF <40% every 3 fewer conducted TTE, and in 4 additional stress imaging per 1 additionally detected ischaemia events. For cardiac stress testing, four more investigations were performed for every 1 additionally detected ischaemia episodes. Use of NT-proBNP did not improve the yield of pathological findings. Multivariable regression analysis failed to find an association between adherence to the updated guidelines and MACE. CONCLUSIONS: The 2022 update for preoperative cardiac testing resulted in a relevant increase in tests receiving a stronger recommendation. The updated recommendations for TTE did not improve the yield of pathological cardiac testing.
引用
- Stroda A, Mauermann E, Ionescu D, et al. Pathological findings associated with the updated European Society of Cardiology 2022 guidelines for preoperative cardiac testing: an observational cohort modelling study. Br J Anaesth. 2024. PMID: 38336516. doi:10.1016/j.bja.2023.12.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。